Art

J-GLOBAL ID：201402242470695400   Reference number：14A1361256

Feasibility Study of Combination Chemotherapy with Paclitaxel, Doxorubicin and Cisplatin without Prophylactic Granulocyte Colony-stimulating Factor Injection for Intermediate-to-high Risk or Recurrent Endometrial Cancer

中間から高リスクまたは再発子宮内膜癌のための予防的顆粒球コロニー刺激因子注射を伴わないパクリタキセルとドキソルビシン,シスプラチンによる併用化学療法の実現可能性調査

Author (7)： NAGAO Shoji (Hyogo Cancer Center, Hyogo) ,  NISHIKAWA Tadaaki (Saitama Medical Univ. International Medical Center, Saitama) ,  HANAOKA Tatsuya (Saitama Medical Univ. Saitama Medical Center, Saitama, JPN) ,  KUROSAKI Akira (Saitama Medical Univ. International Medical Center, Saitama) ,  IWASA Norihiro (Saitama Medical Univ. International Medical Center, Saitama) ,  HASEGAWA Kosei (Saitama Medical Univ. International Medical Center, Saitama) ,  FUJIWARA Keiichi (Saitama Medical Univ. International Medical Center, Saitama)
Material： Japanese Journal of Clinical Oncology  (JJCO)
Volume： 44  Issue： 11  Page： 1040-1044  Publication year： Nov. 2014 
JST Material Number： W2222A  ISSN： 0368-2811  Document type： Article
Article type： 原著論文  Country of issue： United Kingdom (GBR)  Language： ENGLISH (EN)

Thesaurus term： human ,...
Semi thesaurus term： *cisplatin ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=14A1361256&from=J-GLOBAL&jstjournalNo=W2222A") }}

JST classification (3)： Tumors(=neoplasms)of female genitalia and fetus  (GS04000K) ,  Experimental treatment for tumors  (GE02040Y) ,  Clinical application of antitumor(=antineoplastic)drugs  (GW16020L)

Substance index (3)： Doxorubicin ,  Paclitaxel ,  Granisetron

Reference (17)：

• Fleming GF. Systemic chemotherapy for uterine carcinoma: metastatic an adjuvant. J Clin Oncol 2007;25:2983-90.
• Fleming GF, Brunetto VL, Cella D, et al. Phase III trial of doxorubicin plus cisplatin with or without paclitaxel plus filgrastim in advanced endometrial carcinoma: a Gynecologic Oncology Group study. J Clin Oncol 2004;22:2259-66.
• Fleming GF, Fowler JM, Waggoner SE, et al. Phase I trial of escalating dose of paclitaxel combined with fixed doses of cisplatin and doxorubicin in advanced endometrial cancer and other gynecologic malignancies: a Gynecologic Oncology Group study. J Clin Oncol 2001;19:1021-9.
• Cockroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-41.
• Miller D, Filiaci V, Fleming GF, et al. Late-breaking abstract 1: randomized phase III noninferiority trial of first line chemotherapy for metastatic or recurrent endometrial carcinoma: a Gynecologic Oncology Group study. Gynecol Oncol 2012;125:771.

Terms in the title (12)： リスク ,  再発 ,  子宮内膜癌 ,  予防 ,  顆粒球コロニー刺激因子 ,  注射 ,  パクリタキセル ,  ドキソルビシン ,  シスプラチン ,  併用化学療法 ,  実現可能性 ,  調査